On the basis of the information available to it, the Office of Fair
Trading has decided that the proposed acquisition of Profile
Therapeutics Plc by Respironics UK Holding Company Limited does not
qualify for investigation under the mergers provisions of the Enterprise
Act 2002, because neither the UK turnover test nor the share of supply
test in section 23 of the Act is met. A relevant merger situation has,
therefore, not been created.